SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001593968-24-000197
Filing Date
2024-01-31
Accepted
2024-01-31 17:51:47
Documents
1
Period of Report
2024-01-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4  
1 PRIMARY DOCUMENT primary_01.xml 4 5336
  Complete submission text file 0001593968-24-000197.txt   6782
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVE. SANTA MONICA CA 90404
Business Address
MOORE TIMOTHY L. (Reporting) CIK: 0001669207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 24584190

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)